TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.
about
Following a TRAIL: update on a ligand and its five receptorsDeregulation of c-Myc Confers distinct survival requirements for memory B cells, plasma cells, and their progenitorsHuman monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism.Apoptosis of multiple myeloma.A critical role of TRAIL expressed on cotransplanted hepatic stellate cells in prevention of islet allograft rejection.Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.B lymphocytes are resistant to death receptor 5-induced apoptosis.Genetic modification of pigs as organ donors for xenotransplantation.TRAIL modulates the immune system and protects against the development of diabetes.Cell-cycle control of plasma cell differentiation and tumorigenesis.TRAIL and its receptors as targets for cancer therapy.TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects.Hetero-oligomerization between the TNF receptor superfamily members CD40, Fas and TRAILR2 modulate CD40 signallingIn vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.B cell receptor triggering sensitizes human B cells to TRAIL-induced apoptosis.Normal human primary CD4+ T lymphocytes synthesize and release functional osteoprotegerin in vitro.Dendritic Cells Regulate Extrafollicular Autoreactive B Cells via T Cells Expressing Fas and Fas Ligand.Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells.Blockade of Death Ligand TRAIL Inhibits Renal Ischemia Reperfusion Injury.CD27+ B cells from a subgroup of common variable immunodeficiency patients are less sensitive to apoptosis rescue regardless of interleukin-21 signalling.Molecular cloning, expression analysis and assignment of the porcine tumor necrosis factor superfamily member 10 gene (TNFSF10) to SSC13q34-->q36 by fluorescence in situ hybridization and radiation hybrid mapping.Anti-interleukin-6 signalling therapy rebalances the disrupted cytokine production of B cells from patients with active rheumatoid arthritis.Human TNF-related apoptosis-inducing ligand-expressing dendritic cells from transgenic pigs attenuate human xenogeneic T cell responsesDoxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms
P2860
Q28292767-645CE06B-7917-4C81-B0B4-0FC7ADB6B8ADQ30436741-E3A0353E-6941-4417-9658-A2039E301634Q33523440-B5AA3328-73A5-439A-B10F-D1637CECBB3AQ33930178-BF46B694-4D6B-4511-A260-D7A66AA2D71AQ33941348-F58F2D9D-C431-47DF-9AE8-54C1FE9E83ADQ34380431-14EE8389-6802-4519-8015-89914574C965Q34728945-041FF416-6C59-4F7E-9A02-020D53F0B5B3Q35016869-02A28E02-9327-4519-A23C-6EAB7365652BQ35155962-7EDFD701-7357-47CC-9F8A-950143B2B7DFQ35170909-15FBEC9D-C95D-4AA7-9664-F24613BEE12DQ35927476-030ECF08-89B8-44F7-8B2F-2734C374BEF6Q37072767-EB12FE47-5CDA-4FAC-94DD-A333582CB125Q37745184-FBB66FB1-F531-41E2-B2BC-6607DD9E3D27Q39379196-8E3B39BB-9B74-46D5-826A-2B01DF0EB578Q39667395-FC3511D6-E412-485F-BD5F-FC0F7FA506F3Q40044243-56854EDB-A336-45AA-8893-CEBE9A4CBBC8Q40477425-C78C8D3E-1C9F-4023-AA69-59088FF59E63Q41448111-B7B7C953-9AFE-4DEB-A0C6-21E765055EFFQ41966881-B5C00204-A67A-4F85-90BC-4D2E17E301A5Q44034366-7058D62F-C048-4461-8057-CC9B66974B02Q48125951-096EA927-972E-4E9D-9705-80D926103F90Q48162893-BBEC0821-9E49-4C42-A5D1-FB7B2E4CA929Q56775389-41851DDA-C1F2-4E46-944F-7D31201BC417Q57357317-DD3AE7CD-F684-475F-A576-0501CD3245BA
P2860
TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.
@en
type
label
TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.
@en
prefLabel
TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.
@en
P2093
P1476
TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.
@en
P2093
Anne Altmeyer
Eunice N Hatada
Hideo Yagita
Josie Ursini-Siegel
Richard K G Do
Selina Chen-Kiang
Wenli Zhang
P304
P356
10.4049/JIMMUNOL.169.10.5505
P407
P577
2002-11-01T00:00:00Z